Our car spends most of its life parked. Why, then, do we treat it like it only matters when it’s moving? On this episode, we sit down with Norman Lu, Senior Program Manager at Toyota North America, to talk about how to turn EV charging from a source of anxiety into a source of value for car owners. 🚗

Norman joins us to discuss what has changed in battery-electric vehicles over time, why the range is sufficient for most drivers today, and the biggest barriers to EV adoption. He explains how electric vehicles can act as energy storage systems for the grid and how the battery in a single electric vehicle can provide enough power to keep a home running during an outage. Additionally, he shares his thoughts on vehicle-to-grid programs and the problems with the electrical grid today. ⚡️

Norman also shares his thoughts on wireless EV charging, vehicle-to-grid programs, solar on vehicles, and the importance of connectivity for the cars of the future. He also shares with us the challenges of innovation within a giant company like Toyota, and his thoughts on the company’s different approaches to electric vehicles. 📶

_________________________________________________

What does the future of driving look like? Wireless charging, smarter energy use, and more personalized vehicles. 🚗📶 Norman Lu, Senior Program Manager at Toyota North America, gives a look into what’s coming next.

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn

What happens when the heart’s electrical system falls out of rhythm? ❤️

Roderick Tung, MD, Chief, Division of Cardiology, and Director, Cardiovascular Clinical Research, at the University of Arizona in Phoenix, shares how electrophysiology is transforming how doctors understand and treat heart rhythm disorders.

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn

Blood is the currency of clinical trials—and getting it from patient to lab within 48 hours can make or break a study. In this episode, LabConnect CEO Wes Wheeler joins us to discuss how a lab-agnostic model, purpose-built software, and disciplined process design are transforming global clinical research.

Wes breaks down why LabConnect chooses not to own labs and how this decision enables speed, scale, and flexibility across seven key regions where trials are conducted and patients reside. He also unpacks the technology powering their connected ecosystem—unified LIMS, ERP, sample tracking, and data integrations that convert scattered specialty testing into submission-ready data. The result: a network that supports roughly 80% of the data used in new drug applications, while preserving audit trails and regulatory integrity for agencies like the FDA and EMA.

Looking ahead, Wes explores how AI, machine learning, and digital twins are reshaping clinical development—from modeling preclinical safety to identifying recruitable patient populations and flagging anomalies before they impact results. With cell and gene therapies, antibody-drug conjugates, and radiopharma driving the next wave of precision medicine, he shares how LabConnect’s innovation mindset keep trials moving forward.

Along the way, Wes reflects on the mentorship, engineering mindset, and leadership lessons that took him from mechanical engineer to global healthcare executive.

Collaborate with us!

Support the show

For more information about the innovations that are shaping tomorrow's world, head to https://tomorrowsworldtoday.com/

To keep up-to-date with the latest in innovation, technology, sustainability, and more connect with us on social:
YouTube
Instagram
Facebook
Twitter
LinkedIn